INKT实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	27 781.00
平均成交量	100 050
市值	34.01M
EPS	$0 ( 2024-03-21 )
下一个收益日期	( $-0.160 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.510
ATR14	$0.0110 (1.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Behner Peter	Buy	16 185	Common Stock
2024-03-01	Ryan Barbara	Buy	18 685	Common Stock
2024-03-01	Wiinberg Ulf	Buy	15 790	Common Stock
2024-03-01	Corvese Brian	Buy	18 816	Common Stock
2024-01-16	Van Dijk Marcus Antonius	Buy	171 078	Stock Option

INSIDER POWER
-43.62
Last 97 transactions
Buy: 6 422 397 \| Sell: 29 448 104

音量相关性

長: -0.03 (neutral)

短: 0.43 (neutral)

Signal:(47.791) Neutral

MiNK Therapeutics, Inc. 相关性

10 最正相关
MMAC	0.859
EPSN	0.847
CLFD	0.834
NETE	0.828
LYRA	0.825
INPX	0.812
DSGN	0.808
NBIX	0.808
AMRB	0.804
REYN	0.802

10 最负相关
RMRM	-0.834
CPAA	-0.829
TIOAU	-0.826
SVAC	-0.818
MTSL	-0.817
CVCO	-0.814
THCP	-0.813
AEAE	-0.813
PAIC	-0.813
TIOA	-0.81

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

MiNK Therapeutics, Inc. 相关性 - 货币/商品

0.57
( weak )

0.54
( weak )

0.00
( neutral )

-0.61
( weak negative )

MiNK Therapeutics, Inc. 财务报表

Annual	2023
营收:	$0
毛利润:	$-204 617 (0.00 %)
EPS:	$-0.650

FY	2023
营收:	$0
毛利润:	$-204 617 (0.00 %)
EPS:	$-0.650

FY	2022
营收:	$2.70B
毛利润:	$-28.24B (-1 044.26 %)
EPS:	$-0.740

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.160

Financial Reports:

No articles found.

MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.

实时更新： MiNK Therapeutics, Inc. [INKT]

Upcoming Earnings Alert